RICTOR Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RICTOR Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>RICTOR</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Raptor Independent Companion of mTOR</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>5p13.1</td>
</tr>
<tr>
<td class="label">Gene ID (NCBI)</td>
<td>253970</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000164327</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1,708 amino acids</td>
</tr>
<tr>
<td class="label">Protein Type</td>
<td>mTOR Complex Component</td>
</tr>
<tr>
<td class="label">Resource</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Knockout Mice</td>
<td>RICTOR conditional knockout in neurons (RICTOR floxed)</td>
</tr>
<tr>
<td class="label">siRNA/shRNA</td>
<td>Lentiviral constructs for RICTOR knockdown</td>
</tr>
<tr>
<td class="label">Antibodies</td>
<td>Phospho-Akt S473, total RICTOR (multiple vendors)</td>
</tr>
<tr>
<td class="label">Inhibitors</td>
<td>Torin 2 (dual mTORC1/2 inhibitor), AZD8055</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">292 edges</a></td>
</tr>
</table>
Pathway Diagram
Mermaid diagram (expand to render)
Rictor Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Rictor Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@sarbassov2004]
RICTOR (Raptor Independent Companion of [mTOR](/entities/mtor), also known as RICTOR) encodes a critical component of the mechanistic target of rapamycin complex 2 (mTORC2), a key regulator of cell survival, metabolism, and cytoskeletal dynamics. Located on chromosome 5p13.1, the RICTOR gene produces a protein essential for mTORC2 assembly and function, which in turn phosphorylates and activates Akt at Ser473, a pivotal signaling node in neuronal survival pathways [1][2]. [@frias2006]
Gene Overview
Molecular Function
RICTOR serves as the defining subunit of mTORC2, distinguishing it from mTORC1. The molecular functions of RICTOR include: [@griffin2005]
- mTORC2 Assembly: RICTOR partners with mTOR, mSIN1, and Protor-1/2 to form the functional mTORC2 complex [3]
- Akt S473 Phosphorylation: RICTOR is essential for Akt phosphorylation at Ser473, which is required for full Akt activation and downstream signaling [4]
- Cytoskeletal Organization: Through Akt and PKCα signaling, RICTOR regulates actin cytoskeleton dynamics, affecting cell shape, migration, and neuronal morphology [5]
- PKCα Activation: RICTOR-mTORC2 phosphorylates and activates protein kinase C alpha (PKCα), regulating cytoskeletal remodeling [6]
- SGK1 Phosphorylation: mTORC2 phosphorylates serum- and glucocorticoid-regulated kinase 1 (SGK1), affecting ion transport and cell survival [7]
Protein Structure and Interactions
RICTOR is a large protein with multiple functional domains that mediate protein-protein interactions: [@lee2009]
- HEAT repeats: N-terminal region contains [huntingtin](/genes/htt), elongation factor 3, subunit of [PP2A](/entities/pp2a), and TOR (HEAT) repeats involved in protein interactions [8]
- C-terminal region: Contains the domain necessary for mTOR binding and complex formation
- Interaction Partners: RICTOR interacts with mTOR, mSIN1 (MAP4K3), Protor-1 (PRR5L), Protor-2 (PRR5), and CDK2 [9]
The RICTOR-mTORC2 complex localizes primarily to the cytoplasm and plasma membrane, where it receives signals from growth factors, insulin, and cellular stress sensors. [@chen2008]
Signaling Pathways
RICTOR sits at the intersection of several critical signaling cascades: [@horwood2006]
PI3K/Akt/mTOR Pathway
Growth factor signaling through receptor tyrosine kinases activates PI3K, which generates PIP3. This leads to PDK1-mediated Akt T308 phosphorylation, but full Akt activation requires S473 phosphorylation by mTORC2 [10]. RICTOR is therefore essential for complete Akt signaling. [@boland2008]
Insulin Signaling
In [neurons](/entities/neurons), insulin signaling through Akt is crucial for metabolic regulation, synaptic plasticity, and survival. RICTOR-mediated Akt S473 phosphorylation amplifies insulin's neuroprotective effects [11]. [@ries2006]
mTORC1-mTORC2 Cross-talk
mTORC1 negatively regulates mTORC2 assembly through a feedback loop involving S6K1-mediated phosphorylation of RICTOR, creating a complex regulatory network [12]. [@darios2009]
Disease Associations
Alzheimer's Disease
RICTOR and mTORC2 signaling are significantly implicated in Alzheimer's disease pathogenesis: [@santos2010]
- Impaired Akt Signaling: Post-mortem brain studies show reduced Akt S473 phosphorylation in AD patients, associated with RICTOR dysfunction [13]
- Amyloid-β Toxicity: RICTOR/Akt signaling provides neuroprotection against amyloid-β oligomers; impairment exacerbates synaptic dysfunction [14]
- [Tau](/proteins/tau) Pathology: mTORC2/Akt regulates [tau](/proteins/tau) phosphorylation through GSK-3β inhibition; RICTOR deficiency promotes tau hyperphosphorylation [15]
- Synaptic Plasticity: RICTOR-mediated Akt activation is required for [long-term potentiation](/mechanisms/long-term-potentiation) (LTP) and memory formation [16]
- [Autophagy](/entities/autophagy) Dysregulation: mTORC2 signaling regulates autophagy; RICTOR impairment contributes to impaired clearance of toxic proteins in AD [17]
Parkinson's Disease
RICTOR plays protective roles in dopaminergic neurons: [@glass2010]
- Dopaminergic Neuron Survival: RICTOR/Akt signaling protects substantia nigra dopaminergic neurons from apoptotic cell death [18]
- [α-Synuclein](/proteins/alpha-synuclein) Toxicity: RICTOR activation mitigates α-synuclein-induced neurodegeneration through enhanced autophagy [19]
- Mitochondrial Function: mTORC2/Akt regulates mitochondrial dynamics and biogenesis; RICTOR protects against mitochondrial dysfunction in PD models [20]
- Neuroinflammation: RICTOR signaling modulates microglial activation and neuroinflammation in PD [21]
Amyotrophic Lateral Sclerosis (ALS)
- Motor Neuron Survival: RICTOR/Akt signaling is critical for motor neuron survival; dysregulation contributes to ALS pathogenesis [22]
- [TDP-43](/proteins/tdp-43) Pathology: RICTOR protects against [TDP-43](/mechanisms/tdp-43-proteinopathy) aggregation through enhanced protein clearance pathways [23]
Huntington's Disease
- Mutant [Huntingtin](/proteins/huntingtin-protein) Effects: RICTOR expression is altered in HD; mTORC2/Akt signaling intersects with huntingtin toxicity [24]
- Synaptic Dysfunction: RICTOR-mediated signaling regulates synaptic plasticity affected in HD [25]
Therapeutic Implications
mTORC2 Agonists
Small molecules that enhance RICTOR-mTORC2 activity are being explored for neurodegenerative disease treatment: [@sathasivam2015]
- Neuroprotective Strategy: Activating RICTOR/Akt signaling may protect neurons against multiple toxic insults [26]
- Combination Therapy: RICTOR activators combined with mTORC1 inhibitors may provide balanced therapeutic benefit [27]
Challenges
- [Blood-Brain Barrier](/entities/blood-brain-barrier): Therapeutic delivery to the CNS remains challenging
- Complexity of mTOR Networks: Global mTOR activation may have adverse effects
- Timing: Optimal intervention window in disease progression needs clarification
See Also
- [RICTOR Protein](/proteins/rictor-protein)
- [mTOR Signaling](/mechanisms/mtor-signaling-pathway)
- [mTORC1 vs mTORC2](/mechanisms/mtorc1-mtorc2-comparison)
- [Akt Signaling](/proteins/akt-protein)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Huntington's Disease](/diseases/huntingtons)
- [Neuronal Survival Pathways](/mechanisms/neuronal-survival-pathways)
- [Synaptic Plasticity Mechanisms](/mechanisms/synaptic-plasticity)
- [Autophagy in Neurodegeneration](/mechanisms/autophagy-lysosome-neurodegeneration)mechanisms/autophagy-lysosomal-pathway)
- [ GSK-3β ](/entities/gsk3-beta)
- [PKC Alpha](/entities/pkc-alpha)
Overview
Rictor Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Rictor Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Ohwada S, et al, (2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/11583722/)
[Sarbassov DD, et al, (2004) (2004)](https://pubmed.ncbi.nlm.nih.gov/15268862/)
[Frias MA, et al, (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16919458/)
[Alessi DR, et al, (1997) (1997)](https://pubmed.ncbi.nlm.nih.gov/8978681/)
[Jacinto E, et al, (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16962653/)
[Ikenoue T, et al, (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18566587/)
[Garcia-Martinez JM, Alessi DR, (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18925875/)
[Yip CK, et al, (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18550839/)
[Chen CH, et al, (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21757731/)
[Bhaskar PT, Hay N, (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17419990/)
[van der Heide LP, et al, (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16949710/)
[Julien LA, et al, (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/19995915/)
[Griffin RJ, et al, (2005) (2005)](https://pubmed.ncbi.nlm.nih.gov/16155447/)
[Lee HK, et al, (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19308754/)
[Chen Z, et al, (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18931663/)
[Horwood JM, et al, (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16485267/)
[Boland B, et al, (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18596167/)
[Ries V, et al, (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16874051/)
[Darios F, et al, (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19548314/)
[Santos RX, et al, (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20401555/)
[Glass CK, et al, (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20303880/)
[Sathasivam V, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25283288/)
[Liu Y, et al, (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/25086609/)
[Twyffels L, et al, (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21355036/)
[Li SH, Li XJ, (2004) (2004)](https://pubmed.ncbi.nlm.nih.gov/14698520/)
[Perluigi M, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25753925/)
[Mounir Z, et al, (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21283104/)